Prolactinoma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
(13 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}}{{Faizan}},{{Anmol}} | {{CMG}};{{AE}} {{Faizan}}, {{Anmol}} | ||
==Overview== | ==Overview== | ||
[[Prolactinoma]] can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter). | [[Prolactinoma]] can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter). | ||
Line 7: | Line 7: | ||
==Classification== | ==Classification== | ||
Prolactinoma may be classified based on either size or local invasion. | Prolactinoma may be classified based on either size or local invasion. | ||
===Classificatioin based on local invasion<ref name="urlPituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute">{{cite web |url=https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#cit/section_3.3 |title=Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute |format= |work= |accessdate=}}</ref><ref name="pmid09436654">{{cite journal| author=Yeh PJ, Chen JW| title=Pituitary tumors: surgical and medical management. | journal=Surg Oncol | year= 1997 | volume= 6 | issue= 2 | pages= 67-92 | pmid=09436654 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9436654 }}</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref>=== | {| | ||
! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF| Classification of prolactinoma}} | |||
|- | |||
! colspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Classification basis}} | |||
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Type/Grade}} | |||
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Criteria}} | |||
|- | |||
| colspan="2" rowspan= "2" style="background: #DCDCDC; text-align: center;" |Classification based on size<ref name="pmid15274075">{{cite journal |vauthors=Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE |title=The prevalence of pituitary adenomas: a systematic review |journal=Cancer |volume=101 |issue=3 |pages=613–9 |year=2004 |pmid=15274075 |doi=10.1002/cncr.20412 |url=http://onlinelibrary.wiley.com/doi/10.1002/cncr.20412/full}}</ref> | |||
| style="background: #F5F5F5; text-align: center;" |Microprolactinoma | |||
| style="background: #F5F5F5;" | <10 mm diameter | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |Macroprolactinoma | |||
| style="background: #F5F5F5;" | >10 mm diameter | |||
|- | |||
| rowspan="11" style="background: #DCDCDC; text-align: center;" |Classificatioin based on local invasion<ref name="urlPituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute">{{cite web |url=https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#cit/section_3.3 |title=Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute |format= |work= |accessdate=}}</ref><ref name="pmid09436654">{{cite journal| author=Yeh PJ, Chen JW| title=Pituitary tumors: surgical and medical management. | journal=Surg Oncol | year= 1997 | volume= 6 | issue= 2 | pages= 67-92 | pmid=09436654 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9436654 }}</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref> | |||
| rowspan="5" style="background: #DCDCDC; text-align: center;" |Size and Invasion | |||
| style="background: #F5F5F5; text-align: center;" |0 | |||
| style="background: #F5F5F5;" |Normal [[pituitary]] appearance | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |I | |||
| style="background: #F5F5F5;" |Enclosed within the [[sella turcica]], microadenoma smaller than 10 mm | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |II | |||
| style="background: #F5F5F5;" |Enclosed within the [[sella turcica]], macroadenoma 10 mm or larger | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |III | |||
| style="background: #F5F5F5;" |Invasive, locally, into the [[sella turcica]] | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |IV | |||
| style="background: #F5F5F5;" |Invasive, diffusely, into the [[sella turcica]] | |||
|- | |||
| rowspan="4" style="background: #DCDCDC; text-align: center;" |Grading scheme for suprasellar extensions | |||
| style="background: #F5F5F5; text-align: center;" |A | |||
| style="background: #F5F5F5;" |0 to 10 mm [[suprasellar]] extension occupying the [[suprasellar]]cistern | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |B | |||
| style="background: #F5F5F5;" |10 mm to 20 mm extension and elevation of the [[third ventricle]] | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |C | |||
| style="background: #F5F5F5;" |20 mm to 30 mm extension occupying the [[anterior]] of the [[third ventricle]] | |||
|- | |||
| style="background: #F5F5F5; text-align: center;" |D | |||
| style="background: #F5F5F5;" |A larger than 30 mm extension, beyond the [[foramen of Monro]], or Grade C with lateral extensions | |||
|} | |||
== References == | == References == | ||
Line 30: | Line 57: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
| |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 23:49, 29 July 2020
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma classification On the Web |
American Roentgen Ray Society Images of Prolactinoma classification |
Risk calculators and risk factors for Prolactinoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Anmol Pitliya, M.B.B.S. M.D.[3]
Overview
Prolactinoma can be classified based upon either size or local invasion. Based on size, a prolactinoma can be classified as a microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).
Classification
Prolactinoma may be classified based on either size or local invasion.
Classification of prolactinoma | |||
---|---|---|---|
Classification basis | Type/Grade | Criteria | |
Classification based on size[1] | Microprolactinoma | <10 mm diameter | |
Macroprolactinoma | >10 mm diameter | ||
Classificatioin based on local invasion[2][3][4] | Size and Invasion | 0 | Normal pituitary appearance |
I | Enclosed within the sella turcica, microadenoma smaller than 10 mm | ||
II | Enclosed within the sella turcica, macroadenoma 10 mm or larger | ||
III | Invasive, locally, into the sella turcica | ||
IV | Invasive, diffusely, into the sella turcica | ||
Grading scheme for suprasellar extensions | A | 0 to 10 mm suprasellar extension occupying the suprasellarcistern | |
B | 10 mm to 20 mm extension and elevation of the third ventricle | ||
C | 20 mm to 30 mm extension occupying the anterior of the third ventricle | ||
D | A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions |
References
- ↑ Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004). "The prevalence of pituitary adenomas: a systematic review". Cancer. 101 (3): 613–9. doi:10.1002/cncr.20412. PMID 15274075.
- ↑ "Pituitary Tumors Treatment (PDQ®)—Health Professional Version - National Cancer Institute".
- ↑ Yeh PJ, Chen JW (1997). "Pituitary tumors: surgical and medical management". Surg Oncol. 6 (2): 67–92. PMID 09436654.
- ↑ Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98